Invesco
ATOS icon

Invesco’s Atossa Therapeutics ATOS Stock Holding History

Invesco’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,911
Closed -$39.5K – 3771
2025
Q1 		$39.5K Sell
3,911
-112
-3% -$1.36K ﹤0.01% 3717
2024
Q4 		$57K Buy
4,023
+288
+8% +$5.62K ﹤0.01% 3681
2024
Q3 		$85.2K Sell
3,735
-125
-3% -$2.52K ﹤0.01% 3639
2024
Q2 		$68.9K Buy
+3,860
New +$85.4K ﹤0.01% 3791
2022
Q2 		– Sell
-2,185
Closed -$41K – 4045
2022
Q1 		$41K Sell
2,185
-47
-2% -$955 ﹤0.01% 3947
2021
Q4 		$54K Sell
2,232
-240
-10% -$8.78K ﹤0.01% 3971
2021
Q3 		$121K Sell
2,472
-120,952
-98% -$7.04M ﹤0.01% 3903
2021
Q2 		$11.7M Buy
+123,424
New +$6.53M ﹤0.01% 1956
2013
Q4 		– Sell
-19
Closed -$281K – 4328
2013
Q3 		$281K Buy
+19
New +$249K ﹤0.01% 3634

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return